Known targets — ChEMBL curated mechanism
ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB known ✓ | P10828 | 5/20 | 0.64 |
| ▸ | MAPT | P10636 | 5/20 | 0.62 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.62 |
| ▸ | MEN1 | O00255 | 3/20 | 0.62 |
| ▸ | GLO1 | Q04760 | 2/20 | 0.58 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.56 |
| ▸ | GAA | P10253 | 2/20 | 0.56 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.56 |
| ▸ | APP | P05067 | 1/20 | 0.55 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
| ▸ | ALPL | P05186 | 1/20 | 0.53 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.53 |
| ▸ | ALPI | P09923 | 1/20 | 0.53 |
| ▸ | ALPG | P10696 | 1/20 | 0.53 |
| ▸ | CASP3 | P42574 | 1/20 | 0.53 |
| ▸ | RECQL | P46063 | 1/20 | 0.53 |
| ▸ | MMP14 | P50281 | 1/20 | 0.53 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.53 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL136632 | 1.00 | THRB (0.64) | THRBMAPTKMT2AMEN1GLO1 | |
| SCHEMBL144504 | 0.89 | MAPT (0.78) | THRBMAPTKMT2AMEN1GLO1 | |
| SCHEMBL29353711 | 0.89 | MAPT (0.78) | THRBMAPTKMT2AMEN1GLO1 | |
| SCHEMBL29378285 | 0.89 | MAPT (0.78) | THRBMAPTKMT2AMEN1GLO1 | |
| SCHEMBL339399 | 0.89 | MAPT (0.78) | THRBMAPTKMT2AMEN1GLO1 | |
| SCHEMBL16322715 | 0.86 | MAPT (0.78) | THRBMAPTKMT2AMEN1GLO1 | |
| SCHEMBL16322716 | 0.86 | MAPT (0.78) | THRBMAPTKMT2AMEN1GLO1 | |
| SCHEMBL11877643 | 0.86 | MAPT (0.66) | THRBMAPTKMT2AMEN1GLO1 | |
| SCHEMBL11877650 | 0.86 | MAPT (0.66) | THRBMAPTKMT2AMEN1GLO1 | |
| SCHEMBL29421893 | 0.85 | GLO1 (0.64) | THRBMAPTKMT2AMEN1GLO1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 76 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118652800-A | Leucobacillus and application thereof | 绍兴水处理发展有限公司 | 2024-09-17 | — | — | CN | claimed |
| CN-118142365-A | Preparation method of biomacromolecule bridging alginate solvent-resistant gel film | 天津工业大学 | 2024-06-07 | — | — | CN | claimed |
| CN-117247857-A | Heat-resistant heavy metal-resistant mixed bacterial agent, bacterial strain and application thereof in azo dye decolorization | 浙江工业大学 | 2023-12-19 | — | — | CN | claimed |
| CN-112946140-B | Method for detecting water-soluble anion synthetic pigment in food | 广州市食品检验所（广州市酒类检测中心） | 2023-03-21 | — | — | CN | claimed |
| WO-2022188373-A1 | METHOD FOR DETECTING WATER-SOLUBLE ANIONIC SYNTHETIC PIGMENT IN FOOD | 广州市食品检验所（广州市酒类检测中心） | 2022-09-15 | — | — | WO | claimed |
| CN-121571003-A | MOF-808 modified hollow fiber membrane and preparation method thereof | 苏州科技大学 | 2026-02-27 | — | — | CN | disclosed |
| US-20260043720-A1 | STABILIZED TWO-PART HEMATOXYLIN SOLUTION UTILIZING pH ADJUSTMENT | VENTANA MED SYST INC (US) | 2026-02-12 | — | — | US | disclosed |
| US-12496344-B2 | Biophotonic materials and uses thereof | FLE INT S R L (IT) | 2025-12-16 | — | — | US | disclosed |
| US-12497458-B2 | Anti-GAL3 antibodies and uses thereof | TRUEBINDING, INC. (US) | 2025-12-16 | — | — | US | disclosed |
| US-12474240-B2 | Stabilized two-part hematoxylin solution utilizing pH adjustment | VENTANA MEDICAL SYSTEMS, INC. (US) | 2025-11-18 | — | — | US | disclosed |
| US-20250332393-A1 | DEVICES AND METHODS FOR THE TREATMENT OF BODY SURFACE DISORDERS | VERRICA PHARMACEUTICALS INC. (US) | 2025-10-30 | — | — | US | disclosed |
| US-20250319164-A1 | SHEAR-THINNING COMPOSITIONS AS AN INTRAVASCULAR EMBOLIC AGENT | BRIGHAM & WOMENS HOSPITAL INC (US) | 2025-10-16 | — | — | US | disclosed |
| US-11382977-B2 | Biophotonic compositions for treating skin and soft tissue wounds having either or both non-resistant and resistant infections | VETOQUINOL S.A. (FR) | 2022-07-12 | — | — | US | disclosed |
| US-20220178795-A1 | CYTOLOGICAL STAINING COMPOSITIONS AND USES THEREOF | TRIPATH IMAGING, INC. | 2022-06-09 | — | — | US | disclosed |
| US-11331257-B2 | Biophotonic compositions and methods for providing biophotonic treatment | KLOX TECHNOLOGIES INC. (CA) | 2022-05-17 | — | — | US | disclosed |
| US-11324823-B2 | Biophotonic materials and uses thereof | KLOX TECHNOLOGIES INC. (CA) | 2022-05-10 | — | — | US | disclosed |
| EP-3151861-B1 | SILICONE-BASED BIOPHOTONIC COMPOSITIONS AND USES THEREOF | KLOX TECH INC (CA) | 2022-04-06 | — | — | EP | disclosed |
| US-20220090993-A1 | STABILIZED TWO-PART HEMATOXYLIN SOLUTION UTILIZING pH ADJUSTMENT | VENTANA MEDICAL SYSTEMS, INC. | 2022-03-24 | — | — | US | disclosed |
| CN-114209688-A | Compositions, methods, and systems for treating skin conditions | 威瑞卡制药公司 | 2022-03-22 | — | — | CN | disclosed |
| US-11274997-B2 | Cytological staining compositions and uses thereof | TRIPATH IMAGING, INC. (US) | 2022-03-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250332393-A1 | DEVICES AND METHODS FOR THE TREATMENT OF BODY SURFACE DISORDERS | CUTA, TLR5, ATP5PD | THRB 2464/4885MAPT 899/4885KMT2A 3774/4885 |
| US-20260043720-A1 | STABILIZED TWO-PART HEMATOXYLIN SOLUTION UTILIZING pH ADJUSTMENT | SMCHD1, KIT, CD68 | THRB 3803/4885MAPT 1864/4885KMT2A 897/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.